Compare JXN & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JXN | GKOS |
|---|---|---|
| Founded | 1961 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 6.9B |
| IPO Year | N/A | 2015 |
| Metric | JXN | GKOS |
|---|---|---|
| Price | $104.40 | $96.44 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 14 |
| Target Price | $108.80 | ★ $133.07 |
| AVG Volume (30 Days) | 577.7K | ★ 678.3K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 3.44% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $507,442,000.00 |
| Revenue This Year | $17.36 | $23.39 |
| Revenue Next Year | $3.38 | $27.46 |
| P/E Ratio | $16.00 | ★ N/A |
| Revenue Growth | N/A | ★ 32.33 |
| 52 Week Low | $64.70 | $73.16 |
| 52 Week High | $123.61 | $130.23 |
| Indicator | JXN | GKOS |
|---|---|---|
| Relative Strength Index (RSI) | 39.35 | 28.21 |
| Support Level | $103.34 | $93.96 |
| Resistance Level | $109.16 | $97.00 |
| Average True Range (ATR) | 4.37 | 3.77 |
| MACD | -0.87 | -2.37 |
| Stochastic Oscillator | 5.28 | 1.28 |
Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.